Allan Reine
2021 - Foghorn Therapeutics
In 2021, Allan Reine earned a total compensation of $2M as Chief Financial Officer at Foghorn Therapeutics.
Compensation breakdown
Non-Equity Incentive Plan | $249,600 |
---|---|
Option Awards | $1,348,746 |
Salary | $416,000 |
Total | $2,014,346 |
Reine received $1.3M in option awards, accounting for 67% of the total pay in 2021.
Reine also received $249.6K in non-equity incentive plan and $416K in salary.
Rankings
In 2021, Allan Reine's compensation ranked 6,027th out of 12,415 executives tracked by ExecPay. In other words, Reine earned more than 51.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,027 | 52nd |
Manufacturing | 2,552 | 54th |
Chemicals And Allied Products | 1,118 | 53rd |
Drugs | 996 | 53rd |
Pharmaceutical Preparations | 718 | 54th |
Reine's colleagues
We found three more compensation records of executives who worked with Allan Reine at Foghorn Therapeutics in 2021.